Skills this job asks for
BudgetingLeadershipTranslationCommunication
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Corcept Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, Clinical Patient Safety & PV Ops” (Regulatory Affairs Managers) in CA: $245k–$245k, median $245k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Corcept Therapeutics INC paid sponsored hires in similar roles
- 1 certified filing for “Director, Clinical Patient Safety & PV Ops” (Regulatory Affairs Managers) in CA: $245k–$245k, median $245k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.
Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.
Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com .
The Director, Pipeline & Portfolio Market Planning is accountable for shaping and driving Corcept’s oncology portfolio strategies. This leader will guide indication selection and sequencing, competitive landscape assessment, patient journey and treatment paradigm analysis, target product profile (TPP) development, product positioning, and long-range financial forecasting. The Director will serve as a key strategic partner to R&D, Commercial, and Senior Leadership, ensuring data-driven decisions that maximize the value and impact of Corcept’s oncology investments.
Responsibilities:
• Drive and influence program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact
• Provide physician, patient, and payer perspective in clinical strategy and new product planning
• Design, implement, and continuously refine competitive intelligence and market analysis frameworks that proactively inform program decision-making
• Independently lead integrated cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle
• Develop, maintain, and communicate robust long-range revenue forecasts and valuation models to support program planning and resource allocation
• Synthesize market research, competitive intelligence, and analytics into actionable insights to inform executive decision-making
• Own the development and management of target product profiles (TPPs) for pipeline products, working with R&D teams to influence and support decisions
• Lead asset assessments and contribute to business development diligence, guiding executive decision-making
• Oversee and execute ad hoc cross-portfolio workstreams, including global expansion initiatives in partnership with Emerging Markets team
• Model and promote Corcept’s key principles, collaborating effectively, embracing possibilities, following the data, and leading by doing, to build a culture of accountability, innovation, and trust
Preferred Skills, Qualifications and Technical Proficiencies:
• Proven ability to lead strategic planning initiatives across multiple therapeutic areas, integrating scientific, clinical, commercial, and regulatory perspectives
• Deep understanding of the drug development process, spanning early through late-stage programs, with experience translating clinical insights into commercial strategy
• Exceptional executive communication skills; adept at conveying insights and strategies to senior leadership through compelling storytelling
• Strong market research and analytical acumen with the ability to translate data into compelling strategic recommendations
• Skilled at operating effectively in a dynamic, matrixed environment, building alignment and influencing stakeholders across R&D, Commercial, Medical, Finance, and Executive functions
• Proven ability to rapidly synthesize information from multiple internal and external sources
• Occasional travel required for corporate and industry events
Preferred Education and Exp
Apply on employer site ↗